Follicular lymphoma overview

Jump to navigation Jump to search

Follicular lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Follicular lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT scan

MRI

Echocardiography or Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Follicular lymphoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Follicular lymphoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Follicular lymphoma overview

CDC on Follicular lymphoma overview

Follicular lymphoma overview in the news

Blogs on Follicular lymphoma overview

Directions to Hospitals Treating Follicular lymphoma

Risk calculators and risk factors for Follicular lymphoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Follicular lymphoma is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a partially follicular pattern. Follicular lymphoma may be caused by translocation between chromosome 14 and 18 that results in the over expression of the ''BCL-2'' gene. The progression to follicular lymphoma involves the microRNAs (miRNAs). Follicular lymphoma may be classified according to WHO criteria into 3 groups: low grade follicular lymphoma, high grade follicular lymphoma and diffuse large B cell lymphoma. Pediatric-type follicular lymphoma, primary intestinal follicular lymphoma, other extranodal follicular lymphomas and follicular lymphoma “in situ” (FLIS) are the other variants that are included under follicular lymphoma. Follicular lymphoma must be differentiated from other diseases such as diffuse large B cell lymphoma, Mucosa-Associated Lymphatic Tissue lymphoma (MALT), small cell lymphocytic lymphoma, and mantle cell lymphoma (MCL). The prevalence of follicular lymphoma increases with age. Women are more commonly affected. Prognosis of follicular lymphoma is generally poor. The median survival is around 10 years. According to the Lugano classification, there are four stages of follicular lymphoma based on the number of nodes, and extranodal involvement. The most common symptoms of follicular lymphoma include fever, weight loss, night sweats, skin rash, painless swelling in the neck, axilla, groin, thorax, and abdomen, and chest pain, abdominal pain, and bone pain. Common physical examination findings of follicular lymphoma include fever, rash, splenomegaly, peripheral lymphadenopathy, central lymphadenopathy, chest tenderness, abdominal tenderness, and bone tenderness. Laboratory tests of follicular lymphoma includes histologic confirmation, FISH, genetic testing, and immunophenotyping. CT and MRI may be helpful in the diagnosis of follicular lymphoma. The optimal therapy for follicular lymphoma depends on the stage at diagnosis, age, and prognostic scores. The predominant therapy for follicular lymphoma is chemotherapy. Adjunctive hematopoietic stem cell transplantation, and radioimmunotherapy may be required.

Classification

Follicular lymphoma may be classified according to WHO criteria into 3 groups: low grade follicular lymphoma, high grade follicular lymphoma and diffuse large B cell lymphoma. Pediatric-type follicular lymphoma, primary intestinal follicular lymphoma, other extranodal follicular lymphomas, and follicular lymphoma “in situ” (FLIS) are the other variants that are included under follicular lymphoma.

Pathophysiology

Follicular lymphoma is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a partially follicular pattern. Genes involved in the pathogenesis of follicular lymphoma include BCL-2, and BCL-6. The progression to follicular lymphoma involves the microRNAs (miRNAs).

Causes

Follicular lymphoma may be caused by translocation between chromosome 14 and 18 that results in the overexpression of the BCL-2 gene.

Differential Diagnosis

Follicular lymphoma must be differentiated from other diseases such as diffuse large B cell lymphoma, Mucosa-Associated Lymphatic Tissue lymphoma (MALT), small cell lymphocytic lymphoma, and mantle cell lymphoma (MCL).

Epidemiology and Demographics

The prevalence of follicular lymphoma increases with age. Women are more commonly affected.

Prognosis

Prognosis of follicular lymphoma is generally poor. The median survival is around 10 years.

Diagnosis

Staging

According to the Lugano classification, there are four stages of follicular lymphoma based on the number of nodes, and extranodal involvement.

Symptoms

The most common symptoms of follicular lymphoma include fever, weight loss, night sweats, skin rash, painless swelling in the neck,under arm, groin, thorax and abdomen, and chest pain, abdominal pain and bone pain.

Physical Examination

Common physical examination findings of follicular lymphoma include fever, rash, spleenomegaly, peripheral lymphadenopathy, central lymphadenopathy, chest tenderness, abdominal tenderness, and bone tenderness.

Laboratory Findings

Laboratory tests of follicular lymphoma includes histologic confirmation, FISH, genetic testing, and immunophenotyping.

CT

CT scan may be helpful in the diagnosis of follicular lymphoma.

MRI

MRI may be helpful in the diagnosis of follicular lymphoma.

Treatment

Medical Therapy

The optimal therapy for follicular lymphoma depends on the stage at diagnosis, age, and prognostic scores. The predominant therapy for follicular lymphoma is chemotherapy. Adjunctive hematopoietic stem cell transplantation, and radioimmunotherapy may be required.

References